Bo of Zhengzhou race biotechnology co., Ltd., formerly Zhengzhou Bo Sai Institute of biotechnology, established in 1988, is mainly engaged in medical research, production and sales of in vitro diagnostic reagents.1992 year by the provincial science and Technology Commission identified as high-tech enterprises.2009 year by the provincial development and Reform Commission identified as Henan province antibody engineering research center.2010 annual municipal science and Technology Bureau of Zhengzhou antibody engineering technology research center. from my first is the only one being selected in the "national plan of introduction of foreign talents in thousands of" doctor of creative talent of Bai Zhonghu served as the company's General Manager and Chief Scientist, antibody engineering research center in Henan province.

with match stick to independent development, technology innovation over the years, forming a project, research and development, production and sale of organic whole. products now include immunization, biochemical, microbiological and molecular biology fields. the ELISA technique widely at home and abroad, Colloid gold-immunochromatography chromogenic culture technology, micro-organisms, chemical-emitting technologies and terms of hybridoma cell lines secreting monoclonal antibody technology has a mature technology and independent intellectual property rights.

is located in economic development zone, first Avenue, 28th, covering an area of 52 acres, an area of 4500m2 of the first phase registered capital is 20 million Yuan, instruments and equipment more than 10 million Yuan. Bo races through certification: (1) drug manufacturers license, (2) medical device manufacturing enterprise license, and (3) medical device license, and (4) drug GMP certification.

Bo has undertaken and completed the match national torch project item, national scientific and technological projects, province torch projects II, provincial scientific and technical key project four, seven through the provincial identification results. there are seven products, was approved by the Ministry of health produced by the State Drug Administration, four products won the national new drug certificate obtained the national patent of six.2004 year according to national policies, we applied for and obtained national medical device manufacturing license, and have completed more than more than 60 products development and the approval number. bosaiji to existing technology and technology platforms, will develop more new products to serve the society.

personnel: Bo of Zhengzhou race biotechnology co., Ltd. has 160 employees, professional and technical personnel 58. full-time intermediate and senior technical personnel engaged in product development, 26 30 sales personnel. having a professional high-tech enterprise management team. in recent years, attaches great importance to the construction of the scientific research team, constantly strengthen the introduction and training of researchers.

research facilities construction: research base covers an area of 52 acres, an area of 4500m2; pilot base area of 1200m2, instruments and production equipment more than 10 million Yuan. has cell training room 2 between, molecular biology laboratory 2 between, cell laboratory 1 between, prepared room 1 between, and experimental animal Room 8 between, and training places total area 400m2, and million level clean area laboratory 2 between, and enzyme joint immune (ELISA), and colloidal gold, and microbial medium, and chemical glow four section line, has 600m2 100,000 level workshop and 400m2 million level workshop, and laboratory and the GMP work Workshop.

Company General Manager and chief scientist Dr Bai Zhonghu presided over the development of our company has independent intellectual property rights of "full-automatic analysis of random access clinical immune system" (Random access immunoassay system) project, immunodiagnosis of our technology platform, reached the international advanced level, implementation in a short time the company jump-replacement of immunodiagnostic products, Significantly enhanced the company's ability to market competitiveness and open up the international market. the success of the system to achieve high production with independent intellectual property rights of Chinese enterprises "full automatic analysis of random access clinical immune system". it will be China's first fully with independent intellectual property rights the type of clinical analysis of immune system.

company as France Ma companies in mainland China the only agent, for many years for the industry to provide the advanced technology, excellent quality of chromogenic culture media technology. at the 2008 Beijing Olympics chromagar chromogenic medium for the Olympic bid in a exclusive products. national food contaminant detection largest supplier network project-related products.
    fair racing revitalization by means of science and technology, relying on scientific and technological development, leading cadres at all levels and clinical laboratory under the strong support of colleagues throughout the country, size of enterprises has grown, Bo game endless stream of new products, steady development of economic benefits. Bo game's popularity continues to increase and expand products throughout the country. bosaiji to existing technology and technology platforms, will develop more new products to serve the society.